Eurofins Biomnis code

ABACA

Synonyms

• Kivexa®
• Triumeq®
• Trizivir®
• Ziagen®

Specialty

Analytical Chemistry

Clinical significance

HIV antiretroviral, nucleoside analogue, inhibits HIV 1 reverse transcriptase. Oral bioavailability of the order of 80 %, half-life of approximately 1hr30. Its uptake is not modified by the intake of food. Shows good meningeal diffusion. Possible hypersensitivity reactions during the first 6 weeks of treatment. All respiratory, skin or digestive symptoms require an urgent examination. Never represcribe after discontinuation due to intolerance. Risk of lactic acidosis in patients suffering from hepatopathy or obese patients.

Preanalytics

• 3 mL :
• EDTA Plasma centrifuged immediately
•   FROZEN
• Freezing within 4 hours

• A tube specifically for this analysis : No

Further information

Enclose the specific clinical information form (R6-INTGB : Anti-retroviral medicines)
Recommended residual rate, once steady state is reached

Documents to download

• Specific clinical information form (R6-INTGB)

Methodology

HPLC - High Performance Liquid Chromatography

Turnaround time

3 weeks

Caption